Immunopharmacology of pyran copolymer.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002273:Carcinogens; D006801:Humans; D007109:Immunity / Q000187:drug effects; D007369:Interferon Inducers; D008264:Macrophages / Q000187:drug effects; D009369:Neoplasms / Q000188:drug therapy; D019384:Nucleic Acid Synthesis Inhibitors; D011714:Pyrans / Q000276:immunology* / Q000494:pharmacology / Q000627:therapeutic use
D000970:Antineoplastic Agents; D000998:Antiviral Agents; D002273:Carcinogens; D007369:Interferon Inducers; D019384:Nucleic Acid Synthesis Inhibitors; D011714:Pyrans